Cargando…
Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
BACKGROUND: Cardiogenic shock from most causes has unfavorable prognosis. Hypertrophic cardiomyopathy (HCM) can uncommonly present with apical ballooning and shock in association with sudden development of severe and unrelenting left ventricular (LV) outflow obstruction. Typical HCM phenotypic featu...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751867/ https://www.ncbi.nlm.nih.gov/pubmed/34634917 http://dx.doi.org/10.1161/JAHA.121.021141 |
_version_ | 1784631768350982144 |
---|---|
author | Sherrid, Mark V. Swistel, Daniel G. Olivotto, Iacopo Pieroni, Maurizio Wever‐Pinzon, Omar Riedy, Katherine Bach, Richard G. Husaini, Mustafa Cresci, Sharon Reyentovich, Alex Massera, Daniele Maron, Martin S. Maron, Barry J. Kim, Bette |
author_facet | Sherrid, Mark V. Swistel, Daniel G. Olivotto, Iacopo Pieroni, Maurizio Wever‐Pinzon, Omar Riedy, Katherine Bach, Richard G. Husaini, Mustafa Cresci, Sharon Reyentovich, Alex Massera, Daniele Maron, Martin S. Maron, Barry J. Kim, Bette |
author_sort | Sherrid, Mark V. |
collection | PubMed |
description | BACKGROUND: Cardiogenic shock from most causes has unfavorable prognosis. Hypertrophic cardiomyopathy (HCM) can uncommonly present with apical ballooning and shock in association with sudden development of severe and unrelenting left ventricular (LV) outflow obstruction. Typical HCM phenotypic features of mild septal thickening, outflow gradients, and distinctive mitral abnormalities differentiate these patients from others with Takotsubo syndrome, who have normal mitral valves and no outflow obstruction. METHODS AND RESULTS: We analyzed 8 patients from our 4 HCM centers with obstructive HCM and abrupt presentation of cardiogenic shock with LV ballooning, and 6 cases reported in literature. Of 14 patients, 10 (71%) were women, aged 66±9 years, presenting with acute symptoms: LV ballooning; depressed ejection fraction (25±5%); refractory systemic hypotension; marked LV outflow tract obstruction (peak gradient, 94±28 mm Hg); and elevated troponin, but absence of atherosclerotic coronary disease. Shock was managed with intravenous administration of phenylephrine (n=6), norepinephrine (n=6), β‐blocker (n=7), and vasopressin (n=1). Mechanical circulatory support was required in 8, including intra‐aortic balloon pump (n=4), venoarterial extracorporeal membrane oxygenation (n=3), and Impella and Tandem Heart in 1 each. In refractory shock, urgent relief of obstruction by myectomy was performed in 5, and alcohol ablation in 1. All patients survived their critical illness, with full recovery of systolic function. CONCLUSIONS: When cardiogenic shock and LV ballooning occur in obstructive HCM, they are marked by distinctive anatomic and physiologic features. Relief of obstruction with targeted pharmacotherapy, mechanical circulatory support, and myectomy, when necessary for refractory shock, may lead to survival and normalization of systolic function. |
format | Online Article Text |
id | pubmed-8751867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87518672022-01-14 Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy Sherrid, Mark V. Swistel, Daniel G. Olivotto, Iacopo Pieroni, Maurizio Wever‐Pinzon, Omar Riedy, Katherine Bach, Richard G. Husaini, Mustafa Cresci, Sharon Reyentovich, Alex Massera, Daniele Maron, Martin S. Maron, Barry J. Kim, Bette J Am Heart Assoc Brief Communication BACKGROUND: Cardiogenic shock from most causes has unfavorable prognosis. Hypertrophic cardiomyopathy (HCM) can uncommonly present with apical ballooning and shock in association with sudden development of severe and unrelenting left ventricular (LV) outflow obstruction. Typical HCM phenotypic features of mild septal thickening, outflow gradients, and distinctive mitral abnormalities differentiate these patients from others with Takotsubo syndrome, who have normal mitral valves and no outflow obstruction. METHODS AND RESULTS: We analyzed 8 patients from our 4 HCM centers with obstructive HCM and abrupt presentation of cardiogenic shock with LV ballooning, and 6 cases reported in literature. Of 14 patients, 10 (71%) were women, aged 66±9 years, presenting with acute symptoms: LV ballooning; depressed ejection fraction (25±5%); refractory systemic hypotension; marked LV outflow tract obstruction (peak gradient, 94±28 mm Hg); and elevated troponin, but absence of atherosclerotic coronary disease. Shock was managed with intravenous administration of phenylephrine (n=6), norepinephrine (n=6), β‐blocker (n=7), and vasopressin (n=1). Mechanical circulatory support was required in 8, including intra‐aortic balloon pump (n=4), venoarterial extracorporeal membrane oxygenation (n=3), and Impella and Tandem Heart in 1 each. In refractory shock, urgent relief of obstruction by myectomy was performed in 5, and alcohol ablation in 1. All patients survived their critical illness, with full recovery of systolic function. CONCLUSIONS: When cardiogenic shock and LV ballooning occur in obstructive HCM, they are marked by distinctive anatomic and physiologic features. Relief of obstruction with targeted pharmacotherapy, mechanical circulatory support, and myectomy, when necessary for refractory shock, may lead to survival and normalization of systolic function. John Wiley and Sons Inc. 2021-10-12 /pmc/articles/PMC8751867/ /pubmed/34634917 http://dx.doi.org/10.1161/JAHA.121.021141 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Communication Sherrid, Mark V. Swistel, Daniel G. Olivotto, Iacopo Pieroni, Maurizio Wever‐Pinzon, Omar Riedy, Katherine Bach, Richard G. Husaini, Mustafa Cresci, Sharon Reyentovich, Alex Massera, Daniele Maron, Martin S. Maron, Barry J. Kim, Bette Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy |
title | Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy |
title_full | Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy |
title_fullStr | Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy |
title_full_unstemmed | Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy |
title_short | Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy |
title_sort | syndrome of reversible cardiogenic shock and left ventricular ballooning in obstructive hypertrophic cardiomyopathy |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751867/ https://www.ncbi.nlm.nih.gov/pubmed/34634917 http://dx.doi.org/10.1161/JAHA.121.021141 |
work_keys_str_mv | AT sherridmarkv syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT swisteldanielg syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT olivottoiacopo syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT pieronimaurizio syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT weverpinzonomar syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT riedykatherine syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT bachrichardg syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT husainimustafa syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT crescisharon syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT reyentovichalex syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT masseradaniele syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT maronmartins syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT maronbarryj syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy AT kimbette syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy |